Eli Lilly and Company
955.00 CHF+30.00 (+3.24%)
ListedCHF851.6BHealthcareDrug Manufacturers - General50,000 employees
Key Executives(10)
Mr. Donald A. Zakrowski
Senior VP of Finance & Chief Accounting Officer
CompensationNot disclosed
Mr. Ilya Yuffa
Executive VP and President of Lilly USA & Global Customer Capabilities
Age51
CompensationNot disclosed
Dr. Daniel M. Skovronsky M.D., Ph.D.
Chief Scientific & Product Officer and President of Lilly Research Laboratories
Age52
CompensationCHF 4.0M
Ms. Anat Hakim J.D.
Executive VP, General Counsel & Secretary
Age57
CompensationCHF 2.7M
Mr. Jacob S. Van Naarden
Executive VP, President of Lilly Oncology & Head of Corporate Business Development
Age41
CompensationCHF 2.4M
Mr. Diogo Rau
Executive VP and Chief Information & Digital Officer
Age51
CompensationCHF 855K